Big Pharma's 3 Cheapest Stocks

Cheap stocks: They give you more for your money, but they're just as much a mixed bag of strong and poor companies as pricey picks. The price-to-earnings ratio has long been used to judge the general price of a stock, but is this polarizing statistic a good way to value big pharma's ostensibly cheapest stocks?

Using data compiled by stock screening site Finviz, here are the three cheapest major pharmaceutical stocks sorted by P/E. Motley Fool contributor Dan Carroll tells you what you need to know about these picks -- and whether their businesses and outlooks really are worth your money.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

The article Big Pharma's 3 Cheapest Stocks originally appeared on Fool.com.

Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.